The global Inhaler Corticosteroid Device market was valued at US$ 594 million in 2023 and is anticipated to reach US$ 831.5 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.

Inhaler Corticosteroid Device Market

North American market for Inhaler Corticosteroid Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Inhaler Corticosteroid Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Inhaler Corticosteroid Device include Pfizer Inc., GlaxoSmithKline Plc, Novartis AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, AstraZeneca, F. Hoffmann-La Roche Ltd. and Amgen Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Inhaler Corticosteroid Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaler Corticosteroid Device.

Report Scope

The Inhaler Corticosteroid Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inhaler Corticosteroid Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Inhaler Corticosteroid Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Inhaler Corticosteroid Device Market Report

Report Metric	Details
Report Name	Inhaler Corticosteroid Device Market
Accounted market size in 2023	US$ 594 million
Forecasted market size in 2030	US$ 831.5 million
CAGR	4.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Beclomethasone Dipropionate Budesonide Fluticasone Inhaler Powder Mometasone
Segment by Application	Hospitals and Clinics Academic and Research Institutes
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer Inc., GlaxoSmithKline Plc, Novartis AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, AstraZeneca, F. Hoffmann-La Roche Ltd., Amgen Inc., Aurobindo Pharma, Sumitomo Corporation
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhaler Corticosteroid Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhaler Corticosteroid Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Inhaler Corticosteroid Device Market growing?

Ans: The Inhaler Corticosteroid Device Market witnessing a CAGR of 4.9% during the forecast period 2024-2030.

What is the Inhaler Corticosteroid Device Market size in 2030?

Ans: The Inhaler Corticosteroid Device Market size in 2030 will be US$ 831.5 million.

Who are the main players in the Inhaler Corticosteroid Device Market report?

Ans: The main players in the Inhaler Corticosteroid Device Market are Pfizer Inc., GlaxoSmithKline Plc, Novartis AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, AstraZeneca, F. Hoffmann-La Roche Ltd., Amgen Inc., Aurobindo Pharma, Sumitomo Corporation

What are the Application segmentation covered in the Inhaler Corticosteroid Device Market report?

Ans: The Applications covered in the Inhaler Corticosteroid Device Market report are Hospitals and Clinics, Academic and Research Institutes

What are the Type segmentation covered in the Inhaler Corticosteroid Device Market report?

Ans: The Types covered in the Inhaler Corticosteroid Device Market report are Beclomethasone Dipropionate, Budesonide, Fluticasone Inhaler Powder, Mometasone

1 Inhaler Corticosteroid Device Market Overview

1.1 Product Overview and Scope of Inhaler Corticosteroid Device

1.2 Inhaler Corticosteroid Device Segment by Type

1.2.1 Global Inhaler Corticosteroid Device Market Value Comparison by Type (2024-2030)

1.2.2 Beclomethasone Dipropionate

1.2.3 Budesonide

1.2.4 Fluticasone Inhaler Powder

1.2.5 Mometasone

1.3 Inhaler Corticosteroid Device Segment by Application

1.3.1 Global Inhaler Corticosteroid Device Market Value by Application: (2024-2030)

1.3.2 Hospitals and Clinics

1.3.3 Academic and Research Institutes

1.4 Global Inhaler Corticosteroid Device Market Size Estimates and Forecasts

1.4.1 Global Inhaler Corticosteroid Device Revenue 2019-2030

1.4.2 Global Inhaler Corticosteroid Device Sales 2019-2030

1.4.3 Global Inhaler Corticosteroid Device Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Inhaler Corticosteroid Device Market Competition by Manufacturers

2.1 Global Inhaler Corticosteroid Device Sales Market Share by Manufacturers (2019-2024)

2.2 Global Inhaler Corticosteroid Device Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Inhaler Corticosteroid Device Average Price by Manufacturers (2019-2024)

2.4 Global Inhaler Corticosteroid Device Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Inhaler Corticosteroid Device, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Inhaler Corticosteroid Device, Product Type & Application

2.7 Inhaler Corticosteroid Device Market Competitive Situation and Trends

2.7.1 Inhaler Corticosteroid Device Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Inhaler Corticosteroid Device Players Market Share by Revenue

2.7.3 Global Inhaler Corticosteroid Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Inhaler Corticosteroid Device Retrospective Market Scenario by Region

3.1 Global Inhaler Corticosteroid Device Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Inhaler Corticosteroid Device Global Inhaler Corticosteroid Device Sales by Region: 2019-2030

3.2.1 Global Inhaler Corticosteroid Device Sales by Region: 2019-2024

3.2.2 Global Inhaler Corticosteroid Device Sales by Region: 2025-2030

3.3 Global Inhaler Corticosteroid Device Global Inhaler Corticosteroid Device Revenue by Region: 2019-2030

3.3.1 Global Inhaler Corticosteroid Device Revenue by Region: 2019-2024

3.3.2 Global Inhaler Corticosteroid Device Revenue by Region: 2025-2030

3.4 North America Inhaler Corticosteroid Device Market Facts & Figures by Country

3.4.1 North America Inhaler Corticosteroid Device Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Inhaler Corticosteroid Device Sales by Country (2019-2030)

3.4.3 North America Inhaler Corticosteroid Device Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Inhaler Corticosteroid Device Market Facts & Figures by Country

3.5.1 Europe Inhaler Corticosteroid Device Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Inhaler Corticosteroid Device Sales by Country (2019-2030)

3.5.3 Europe Inhaler Corticosteroid Device Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Inhaler Corticosteroid Device Market Facts & Figures by Country

3.6.1 Asia Pacific Inhaler Corticosteroid Device Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Inhaler Corticosteroid Device Sales by Country (2019-2030)

3.6.3 Asia Pacific Inhaler Corticosteroid Device Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Inhaler Corticosteroid Device Market Facts & Figures by Country

3.7.1 Latin America Inhaler Corticosteroid Device Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Inhaler Corticosteroid Device Sales by Country (2019-2030)

3.7.3 Latin America Inhaler Corticosteroid Device Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Inhaler Corticosteroid Device Market Facts & Figures by Country

3.8.1 Middle East and Africa Inhaler Corticosteroid Device Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Inhaler Corticosteroid Device Sales by Country (2019-2030)

3.8.3 Middle East and Africa Inhaler Corticosteroid Device Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Inhaler Corticosteroid Device Sales by Type (2019-2030)

4.1.1 Global Inhaler Corticosteroid Device Sales by Type (2019-2024)

4.1.2 Global Inhaler Corticosteroid Device Sales by Type (2025-2030)

4.1.3 Global Inhaler Corticosteroid Device Sales Market Share by Type (2019-2030)

4.2 Global Inhaler Corticosteroid Device Revenue by Type (2019-2030)

4.2.1 Global Inhaler Corticosteroid Device Revenue by Type (2019-2024)

4.2.2 Global Inhaler Corticosteroid Device Revenue by Type (2025-2030)

4.2.3 Global Inhaler Corticosteroid Device Revenue Market Share by Type (2019-2030)

4.3 Global Inhaler Corticosteroid Device Price by Type (2019-2030)

5 Segment by Application

5.1 Global Inhaler Corticosteroid Device Sales by Application (2019-2030)

5.1.1 Global Inhaler Corticosteroid Device Sales by Application (2019-2024)

5.1.2 Global Inhaler Corticosteroid Device Sales by Application (2025-2030)

5.1.3 Global Inhaler Corticosteroid Device Sales Market Share by Application (2019-2030)

5.2 Global Inhaler Corticosteroid Device Revenue by Application (2019-2030)

5.2.1 Global Inhaler Corticosteroid Device Revenue by Application (2019-2024)

5.2.2 Global Inhaler Corticosteroid Device Revenue by Application (2025-2030)

5.2.3 Global Inhaler Corticosteroid Device Revenue Market Share by Application (2019-2030)

5.3 Global Inhaler Corticosteroid Device Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Pfizer Inc.

6.1.1 Pfizer Inc. Corporation Information

6.1.2 Pfizer Inc. Description and Business Overview

6.1.3 Pfizer Inc. Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Pfizer Inc. Inhaler Corticosteroid Device Product Portfolio

6.1.5 Pfizer Inc. Recent Developments/Updates

6.2 GlaxoSmithKline Plc

6.2.1 GlaxoSmithKline Plc Corporation Information

6.2.2 GlaxoSmithKline Plc Description and Business Overview

6.2.3 GlaxoSmithKline Plc Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2019-2024)

6.2.4 GlaxoSmithKline Plc Inhaler Corticosteroid Device Product Portfolio

6.2.5 GlaxoSmithKline Plc Recent Developments/Updates

6.3 Novartis AG

6.3.1 Novartis AG Corporation Information

6.3.2 Novartis AG Description and Business Overview

6.3.3 Novartis AG Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Novartis AG Inhaler Corticosteroid Device Product Portfolio

6.3.5 Novartis AG Recent Developments/Updates

6.4 Mylan NV

6.4.1 Mylan NV Corporation Information

6.4.2 Mylan NV Description and Business Overview

6.4.3 Mylan NV Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Mylan NV Inhaler Corticosteroid Device Product Portfolio

6.4.5 Mylan NV Recent Developments/Updates

6.5 Teva Pharmaceutical Industries Ltd.

6.5.1 Teva Pharmaceutical Industries Ltd. Corporation Information

6.5.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview

6.5.3 Teva Pharmaceutical Industries Ltd. Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Teva Pharmaceutical Industries Ltd. Inhaler Corticosteroid Device Product Portfolio

6.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates

6.6 Boehringer Ingelheim International GmbH

6.6.1 Boehringer Ingelheim International GmbH Corporation Information

6.6.2 Boehringer Ingelheim International GmbH Description and Business Overview

6.6.3 Boehringer Ingelheim International GmbH Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Boehringer Ingelheim International GmbH Inhaler Corticosteroid Device Product Portfolio

6.6.5 Boehringer Ingelheim International GmbH Recent Developments/Updates

6.7 AstraZeneca

6.6.1 AstraZeneca Corporation Information

6.6.2 AstraZeneca Description and Business Overview

6.6.3 AstraZeneca Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2019-2024)

6.4.4 AstraZeneca Inhaler Corticosteroid Device Product Portfolio

6.7.5 AstraZeneca Recent Developments/Updates

6.8 F. Hoffmann-La Roche Ltd.

6.8.1 F. Hoffmann-La Roche Ltd. Corporation Information

6.8.2 F. Hoffmann-La Roche Ltd. Description and Business Overview

6.8.3 F. Hoffmann-La Roche Ltd. Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2019-2024)

6.8.4 F. Hoffmann-La Roche Ltd. Inhaler Corticosteroid Device Product Portfolio

6.8.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates

6.9 Amgen Inc.

6.9.1 Amgen Inc. Corporation Information

6.9.2 Amgen Inc. Description and Business Overview

6.9.3 Amgen Inc. Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Amgen Inc. Inhaler Corticosteroid Device Product Portfolio

6.9.5 Amgen Inc. Recent Developments/Updates

6.10 Aurobindo Pharma

6.10.1 Aurobindo Pharma Corporation Information

6.10.2 Aurobindo Pharma Description and Business Overview

6.10.3 Aurobindo Pharma Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Aurobindo Pharma Inhaler Corticosteroid Device Product Portfolio

6.10.5 Aurobindo Pharma Recent Developments/Updates

6.11 Sumitomo Corporation

6.11.1 Sumitomo Corporation Corporation Information

6.11.2 Sumitomo Corporation Inhaler Corticosteroid Device Description and Business Overview

6.11.3 Sumitomo Corporation Inhaler Corticosteroid Device Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Sumitomo Corporation Inhaler Corticosteroid Device Product Portfolio

6.11.5 Sumitomo Corporation Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Inhaler Corticosteroid Device Industry Chain Analysis

7.2 Inhaler Corticosteroid Device Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Inhaler Corticosteroid Device Production Mode & Process

7.4 Inhaler Corticosteroid Device Sales and Marketing

7.4.1 Inhaler Corticosteroid Device Sales Channels

7.4.2 Inhaler Corticosteroid Device Distributors

7.5 Inhaler Corticosteroid Device Customers

8 Inhaler Corticosteroid Device Market Dynamics

8.1 Inhaler Corticosteroid Device Industry Trends

8.2 Inhaler Corticosteroid Device Market Drivers

8.3 Inhaler Corticosteroid Device Market Challenges

8.4 Inhaler Corticosteroid Device Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Boehringer Ingelheim International GmbH

Astrazeneca plc

F Hoffmann La Roche Ltd

Amgen Inc

Aurobindo Pharma

Sumitomo Corporation

List of Tables

Table 1. Global Inhaler Corticosteroid Device Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Inhaler Corticosteroid Device Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Inhaler Corticosteroid Device Market Competitive Situation by Manufacturers in 2023

Table 4. Global Inhaler Corticosteroid Device Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Inhaler Corticosteroid Device Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Inhaler Corticosteroid Device Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Inhaler Corticosteroid Device Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Inhaler Corticosteroid Device Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Inhaler Corticosteroid Device, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Inhaler Corticosteroid Device, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Inhaler Corticosteroid Device, Product Type & Application

Table 12. Global Key Manufacturers of Inhaler Corticosteroid Device, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Inhaler Corticosteroid Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaler Corticosteroid Device as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Inhaler Corticosteroid Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Inhaler Corticosteroid Device Sales by Region (2019-2024) & (K Units)

Table 18. Global Inhaler Corticosteroid Device Sales Market Share by Region (2019-2024)

Table 19. Global Inhaler Corticosteroid Device Sales by Region (2025-2030) & (K Units)

Table 20. Global Inhaler Corticosteroid Device Sales Market Share by Region (2025-2030)

Table 21. Global Inhaler Corticosteroid Device Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Inhaler Corticosteroid Device Revenue Market Share by Region (2019-2024)

Table 23. Global Inhaler Corticosteroid Device Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Inhaler Corticosteroid Device Revenue Market Share by Region (2025-2030)

Table 25. North America Inhaler Corticosteroid Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Inhaler Corticosteroid Device Sales by Country (2019-2024) & (K Units)

Table 27. North America Inhaler Corticosteroid Device Sales by Country (2025-2030) & (K Units)

Table 28. North America Inhaler Corticosteroid Device Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Inhaler Corticosteroid Device Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Inhaler Corticosteroid Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Inhaler Corticosteroid Device Sales by Country (2019-2024) & (K Units)

Table 32. Europe Inhaler Corticosteroid Device Sales by Country (2025-2030) & (K Units)

Table 33. Europe Inhaler Corticosteroid Device Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Inhaler Corticosteroid Device Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Inhaler Corticosteroid Device Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Inhaler Corticosteroid Device Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Inhaler Corticosteroid Device Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Inhaler Corticosteroid Device Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Inhaler Corticosteroid Device Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Inhaler Corticosteroid Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Inhaler Corticosteroid Device Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Inhaler Corticosteroid Device Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Inhaler Corticosteroid Device Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Inhaler Corticosteroid Device Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Inhaler Corticosteroid Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Inhaler Corticosteroid Device Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Inhaler Corticosteroid Device Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Inhaler Corticosteroid Device Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Inhaler Corticosteroid Device Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Inhaler Corticosteroid Device Sales (K Units) by Type (2019-2024)

Table 51. Global Inhaler Corticosteroid Device Sales (K Units) by Type (2025-2030)

Table 52. Global Inhaler Corticosteroid Device Sales Market Share by Type (2019-2024)

Table 53. Global Inhaler Corticosteroid Device Sales Market Share by Type (2025-2030)

Table 54. Global Inhaler Corticosteroid Device Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Inhaler Corticosteroid Device Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Inhaler Corticosteroid Device Revenue Market Share by Type (2019-2024)

Table 57. Global Inhaler Corticosteroid Device Revenue Market Share by Type (2025-2030)

Table 58. Global Inhaler Corticosteroid Device Price (US$/Unit) by Type (2019-2024)

Table 59. Global Inhaler Corticosteroid Device Price (US$/Unit) by Type (2025-2030)

Table 60. Global Inhaler Corticosteroid Device Sales (K Units) by Application (2019-2024)

Table 61. Global Inhaler Corticosteroid Device Sales (K Units) by Application (2025-2030)

Table 62. Global Inhaler Corticosteroid Device Sales Market Share by Application (2019-2024)

Table 63. Global Inhaler Corticosteroid Device Sales Market Share by Application (2025-2030)

Table 64. Global Inhaler Corticosteroid Device Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Inhaler Corticosteroid Device Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Inhaler Corticosteroid Device Revenue Market Share by Application (2019-2024)

Table 67. Global Inhaler Corticosteroid Device Revenue Market Share by Application (2025-2030)

Table 68. Global Inhaler Corticosteroid Device Price (US$/Unit) by Application (2019-2024)

Table 69. Global Inhaler Corticosteroid Device Price (US$/Unit) by Application (2025-2030)

Table 70. Pfizer Inc. Corporation Information

Table 71. Pfizer Inc. Description and Business Overview

Table 72. Pfizer Inc. Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Pfizer Inc. Inhaler Corticosteroid Device Product

Table 74. Pfizer Inc. Recent Developments/Updates

Table 75. GlaxoSmithKline Plc Corporation Information

Table 76. GlaxoSmithKline Plc Description and Business Overview

Table 77. GlaxoSmithKline Plc Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. GlaxoSmithKline Plc Inhaler Corticosteroid Device Product

Table 79. GlaxoSmithKline Plc Recent Developments/Updates

Table 80. Novartis AG Corporation Information

Table 81. Novartis AG Description and Business Overview

Table 82. Novartis AG Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Novartis AG Inhaler Corticosteroid Device Product

Table 84. Novartis AG Recent Developments/Updates

Table 85. Mylan NV Corporation Information

Table 86. Mylan NV Description and Business Overview

Table 87. Mylan NV Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Mylan NV Inhaler Corticosteroid Device Product

Table 89. Mylan NV Recent Developments/Updates

Table 90. Teva Pharmaceutical Industries Ltd. Corporation Information

Table 91. Teva Pharmaceutical Industries Ltd. Description and Business Overview

Table 92. Teva Pharmaceutical Industries Ltd. Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Teva Pharmaceutical Industries Ltd. Inhaler Corticosteroid Device Product

Table 94. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates

Table 95. Boehringer Ingelheim International GmbH Corporation Information

Table 96. Boehringer Ingelheim International GmbH Description and Business Overview

Table 97. Boehringer Ingelheim International GmbH Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Boehringer Ingelheim International GmbH Inhaler Corticosteroid Device Product

Table 99. Boehringer Ingelheim International GmbH Recent Developments/Updates

Table 100. AstraZeneca Corporation Information

Table 101. AstraZeneca Description and Business Overview

Table 102. AstraZeneca Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. AstraZeneca Inhaler Corticosteroid Device Product

Table 104. AstraZeneca Recent Developments/Updates

Table 105. F. Hoffmann-La Roche Ltd. Corporation Information

Table 106. F. Hoffmann-La Roche Ltd. Description and Business Overview

Table 107. F. Hoffmann-La Roche Ltd. Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. F. Hoffmann-La Roche Ltd. Inhaler Corticosteroid Device Product

Table 109. F. Hoffmann-La Roche Ltd. Recent Developments/Updates

Table 110. Amgen Inc. Corporation Information

Table 111. Amgen Inc. Description and Business Overview

Table 112. Amgen Inc. Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Amgen Inc. Inhaler Corticosteroid Device Product

Table 114. Amgen Inc. Recent Developments/Updates

Table 115. Aurobindo Pharma Corporation Information

Table 116. Aurobindo Pharma Description and Business Overview

Table 117. Aurobindo Pharma Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Aurobindo Pharma Inhaler Corticosteroid Device Product

Table 119. Aurobindo Pharma Recent Developments/Updates

Table 120. Sumitomo Corporation Corporation Information

Table 121. Sumitomo Corporation Description and Business Overview

Table 122. Sumitomo Corporation Inhaler Corticosteroid Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Sumitomo Corporation Inhaler Corticosteroid Device Product

Table 124. Sumitomo Corporation Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Inhaler Corticosteroid Device Distributors List

Table 128. Inhaler Corticosteroid Device Customers List

Table 129. Inhaler Corticosteroid Device Market Trends

Table 130. Inhaler Corticosteroid Device Market Drivers

Table 131. Inhaler Corticosteroid Device Market Challenges

Table 132. Inhaler Corticosteroid Device Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Inhaler Corticosteroid Device

Figure 2. Global Inhaler Corticosteroid Device Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Inhaler Corticosteroid Device Market Share by Type in 2023 & 2030

Figure 4. Beclomethasone Dipropionate Product Picture

Figure 5. Budesonide Product Picture

Figure 6. Fluticasone Inhaler Powder Product Picture

Figure 7. Mometasone Product Picture

Figure 8. Global Inhaler Corticosteroid Device Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Inhaler Corticosteroid Device Market Share by Application in 2023 & 2030

Figure 10. Hospitals and Clinics

Figure 11. Academic and Research Institutes

Figure 12. Global Inhaler Corticosteroid Device Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Inhaler Corticosteroid Device Market Size (2019-2030) & (US$ Million)

Figure 14. Global Inhaler Corticosteroid Device Sales (2019-2030) & (K Units)

Figure 15. Global Inhaler Corticosteroid Device Average Price (US$/Unit) & (2019-2030)

Figure 16. Inhaler Corticosteroid Device Report Years Considered

Figure 17. Inhaler Corticosteroid Device Sales Share by Manufacturers in 2023

Figure 18. Global Inhaler Corticosteroid Device Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Inhaler Corticosteroid Device Players: Market Share by Revenue in 2023

Figure 20. Inhaler Corticosteroid Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Inhaler Corticosteroid Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Inhaler Corticosteroid Device Sales Market Share by Country (2019-2030)

Figure 23. North America Inhaler Corticosteroid Device Revenue Market Share by Country (2019-2030)

Figure 24. United States Inhaler Corticosteroid Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Inhaler Corticosteroid Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Inhaler Corticosteroid Device Sales Market Share by Country (2019-2030)

Figure 27. Europe Inhaler Corticosteroid Device Revenue Market Share by Country (2019-2030)

Figure 28. Germany Inhaler Corticosteroid Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Inhaler Corticosteroid Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Inhaler Corticosteroid Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Inhaler Corticosteroid Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Inhaler Corticosteroid Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Inhaler Corticosteroid Device Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Inhaler Corticosteroid Device Revenue Market Share by Region (2019-2030)

Figure 35. China Inhaler Corticosteroid Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Inhaler Corticosteroid Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Inhaler Corticosteroid Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Inhaler Corticosteroid Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Inhaler Corticosteroid Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Inhaler Corticosteroid Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Inhaler Corticosteroid Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Latin America Inhaler Corticosteroid Device Sales Market Share by Country (2019-2030)

Figure 43. Latin America Inhaler Corticosteroid Device Revenue Market Share by Country (2019-2030)

Figure 44. Mexico Inhaler Corticosteroid Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Brazil Inhaler Corticosteroid Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Argentina Inhaler Corticosteroid Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Inhaler Corticosteroid Device Sales Market Share by Country (2019-2030)

Figure 48. Middle East & Africa Inhaler Corticosteroid Device Revenue Market Share by Country (2019-2030)

Figure 49. Turkey Inhaler Corticosteroid Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Inhaler Corticosteroid Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. UAE Inhaler Corticosteroid Device Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Global Sales Market Share of Inhaler Corticosteroid Device by Type (2019-2030)

Figure 53. Global Revenue Market Share of Inhaler Corticosteroid Device by Type (2019-2030)

Figure 54. Global Inhaler Corticosteroid Device Price (US$/Unit) by Type (2019-2030)

Figure 55. Global Sales Market Share of Inhaler Corticosteroid Device by Application (2019-2030)

Figure 56. Global Revenue Market Share of Inhaler Corticosteroid Device by Application (2019-2030)

Figure 57. Global Inhaler Corticosteroid Device Price (US$/Unit) by Application (2019-2030)

Figure 58. Inhaler Corticosteroid Device Value Chain

Figure 59. Inhaler Corticosteroid Device Production Process

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Distributors Profiles

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions